Prognostic significance of pretreatment serum carcinoembryonic antigen levels in gastric cancer with pathological lymph node-negative: A large sample single-center retrospective study

Table 2 Multivariate analysis for stage pTxN0M0 gastric cancer patients with D2 resection

	Univariate analysis				Multivariate analysis
	P value	Exp(B)	95%CI used for Exp (B)		P value	Exp (B)	95%CI used for Exp (B)
			Lower	Upper			Lower	Upper
Family history	0.912	0.923	0.765	1.311	0.069	1.017	0.72	1.896
HP infection status	0.209	0.832	0.781	1.226	0.754	1.088	0.643	1.840
Gender	0.000a	1.716	1.316	2.553	0.590	0.898	0.608	1.327
CEA	0.000a	1.919	1.319	2.352	0.000a	1.924	1.353	2.232
Location	0.245	0.841	0.792	1.234	0.749	1.012	0.861	1.531
Lauren classification	0.241	0.851	0.814	1.091	0.711	1.109	0.891	1.154
T category	0.000a	1.906	1.659	2.271	0.009a	1.714	1.050	2.403
Differentiation degree	0.279	0.932	0.881	1.126	0.784	1.188	0.663	1.640
Nerve invasion	0.971	0.801	0.731	1.145	0.097	0.951	0.7768	1.655
Vessel carcinoma embolus	0.000a	1.764	1.321	2.562	0.983	0.994	0.895	1.660
BMI	0.732	0.812	0.729	1.234	0.356	1.228	0.912	2.229

^aP < 0.05. HP: Helicobacter pylori; BMI: Body mass index; CEA: Carcinoembryonic antigen.